Effect of oral administration and topical gel application of thymol and low-level laser therapy on oxidative stress, inflammatory biomarkers and dermatitis in patients with type 2 diabetes mellitus

Authors

  • Danik Martirosyan Functional Food Center, Functional Food Institute, Dallas, TX, USA
  • Fahimeh Jahanbakhshi Nano Bio Electronic Devices Lab, Cancer Electronics Research Group, School of Electrical and Computer Engineering, College of Engineering, University of Tehran, Iran;
  • Mohammad Reza Ashoori Department of Laboratory Sciences, School of Allied Medical Sciences, Zanjan University of Medical Sciences, Zanjan, Iran
  • Saham Alkhamis Laser and Plasma Research Institute, Shahid Beheshti University, G. C., Tehran, Iran
  • Shaghayegh Pezeshki Department of Immunology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
  • Afsaneh Seyed Mikaeili Department of Molecular and Cellular Sciences, Faculty of Advanced Sciences and Technology, Islamic Azad University, Pharmaceutical Sciences Branch, Tehran, Iran
  • Hossein Mirmiranpour Endocrinology and Metabolism Research Center (EMRC), Valiasr Hospital, School of Medicine, Tehran University of Medical Science, Tehran, Iran

DOI:

https://doi.org/10.31989/bchd.v5i4.910

Abstract

Background:Unmanaged diabetes mellitus, as a chronic metabolic disease, has dangerous consequences. The consequences of diabetes can be delayed and controlled by using antioxidants and anti-inflammatory substances in the food compounds.

Objective: One of the main objectives of this study was to evaluate thymol administration and low-level laser therapy on the change of inflammatory and, oxidative indicators, and lipid profiles in patients with type 2 diabetes. Another aim was to study the effect of thymol oil extract on dermatitis.

Methods:Thirty volunteers with type 2 diabetes and thirty healthy volunteers as controls were selected. Blood samples were taken from all subjects before the study. The diabetic group was divided into four groups: untreated, treated with low-level laser, treated with thymol (25 mg/kg/30 days) and treated with thymol and laser. Glucose, advanced glycation end products, malondialdehyde, oxidized low level laser, reactive oxygen species, peroxide hydrogen, total cholesterol, triglyceride, and inflammatory cytokines such as tumor necrosis factor alpha, interleukin-1 beta and interleukin-1 alpha were measured and compared between diabetic and control groups and within diabetic groups. Thymol gel oil extract (0.5%) was studied in reduction of dermatitis in the feet of the diabetic group.

Results:Thymol administration, along with low-level laser therapy, reduced levels of cytokines except for interleukin-1 alpha, total cholesterol, triglycerides, advanced glycation end products, hydrogen peroxide, malondialdehyde, and oxidized low density level lipoprotein (P value < 0.05). The effect of 0.5% thymol oil as a gel on the reduction of dermatitis was not significant.

Conclusion:Thymol administration and thymol gel as well as low-level laser therapy, as adjunctive methods, through the reduction of free radicals and oxidative stress can be useful in controlling and reducing the diabetes complications.

Keywords: Diabetes mellitus, Thymol, Topical gel, Low-level laser therapy, Dermatitis

Downloads

Published

2022-04-27

Issue

Vol. 5 No. 4 (2022): April 2022

Section

Research Articles

License

Any manuscripts or substantial parts of it, submitted to the journal must not be under consideration by or previously published in any other journal or citable form. Authors are required to ensure that no material submitted as part of a manuscript infringes existing copyrights or the rights of a third party. In submitting one's article in any form, the author has assigned the FFC publishing rights and has agreed to an automatic transfer of the copyright to the publisher. This is so that the FFC may create print option journals, for example, at the FFC’s discretion. If the author wishes to distribute their works by means outside of the FFC, for example within their community, they will have to place a request. 

 

Correspondence concerning articles published in Functional Foods in Health and Disease is encouraged. While derivative works (adaptations, extensions on the current work, etc.) are allowed, distribution of the modified material is not allowed without permission from the FFC.